P13 antigens from Borrelia
AssigneeSymbicom Aktiebolag
InventorSven Bergström
Life of this patent
Estimating the term…
Loading patent…
AssigneeSymbicom Aktiebolag
InventorSven Bergström
Estimating the term…
The invention relates to an isolated nucleic acid fragment which encodes a polypeptide fragment which exhibits a substantial immunological reactivity with a rabbit polyclonal antibody raised against a polypeptide having an apparent molecular weight of 13 kDa as determined by SDS-PAGE followed by visualization, said polypeptide being derived from Borrelia burgdorferi B313 and being encoded by the nucleotide sequence of SEQ ID NO: 18, said rabbit polyclonal antibody exhibiting substantially no immunological reactivity with proteins from at least 95% of spirochaetes randomly selected from the group consisting of Borrelia hermsii, Borrelia crocidurae, Borrelia anserina, and Borrelia hispanica, and/or hybridises readily under highly stringent hybridization conditions with a DNA fragment having a nucleotide sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 20, and SEQ ID NO: 22, or with a DNA fragment complementary thereto, but exhibits no substantial hybridization when the hybridization conditions are highly stringent with genomic DNA from at least 95% of spirochaetes randomly selected from the group consisting of Borrelia hermsii, Borrelia crocidurae, Borrelia anserina, and Borrelia hispanica. Furthermore, the invention relates to polypeptide fragments, vectors, transformed cells and cell lines, a method of preparing a polypeptide fragment and, vaccines as well as diagnostic compositions and kits.
An isolated nucleic acid molecule which
An isolated nucleic acid molecule that comprises SEQ ID NO:
An isolated nucleic acid molecule that encodes SEQ ID NO:
Dependencies are inferred from the claim text.